On May 12, 2022 ArcticZymes Technologies reported that it is attending the ASGCT (Free ASGCT Whitepaper) 25th Annual Meeting in Washington, D.C. from – May 16-19 (Press release, Biotec Pharmacon, MAY 12, 2022, View Source [SID1234614281]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Mr. Scott Frayo is looking forward to meeting you at booth 241 for a discussion on how our SAN HQ, SAN HQ 2.0 and M-SAN HQ can improve the efficiency of your viral bioprocessing process.

Our salt active nuclease (SAN) enzymes have been validated for AV, AAV and LV purification. ArcticZymes Technologies therefore supplies different nucleases for the purification of viral gene vectors or oncolytic virus that you may need for your manufacturing process.